Delivery Order SPE2DR25D1104-SPE2DR26FK108
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,941.91 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the DLA's medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Cryselle-28 tablets (a contraceptive medication) under a firm fixed-price contract structure. The award, valued at $1,643.68, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, an approximately $1 billion prime vendor agreement running through December 2026. The delivery order carries no...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,702.12, is for the delivery of CRYSELLE-28 TABLET 28S medical supplies. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price contract type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $45,474.95 to AmerisourceBergen Drug Corp on October 30, 2025, for pharmaceutical products and medical supplies under a firm fixed price contract. This non-competitive delivery order, with an ultimate completion date of October 31, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $28,637.82 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is set for ultimate completion on August 12, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,954.56 for ORSERDU 345 mg tablets (30-count) on October 20, 2025, with completion scheduled for November 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $36,367.76 to AmerisourceBergen Drug Corp on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $15,695.78 by the Defense Logistics Agency's Medical Supply Chain on September 22, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 23, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency's Medical Supply Chain awarded a $3,562.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, with completion expected by August 29, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2026. The delivery order was fulfilled from AmerisourceBergen's Corporate Office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,586.56 by the Defense Logistics Agency's Medical Supply Chain on October 13, 2025, with an ultimate completion date of October 14, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order is a child contract issued under AmerisourceBergen's...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK108Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cryselle-28 tablets (28-count packaging) on October 22, 2025, with a ceiling value of $1,089.41 and completion targeted for October 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly for military and veteran healthcare systems. As a major healthcare solutions provider, the company maintains an extensive portfolio of federal contract awards covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's demonstrated capability to fulfill federal medical supply requirements through open competition, combined with its role as a prime vendor under the DLA Troop Support Medical IDC, positions it to deliver essential pharmaceutical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/22/25 |